Understanding the Jewish-Cancer Connection

Top Pick May 23, 2018 Wellesley Free 0
Photo for Jewish Boston's Calendar

Temple Beth Elohim is graciously hosting this Oneinforty symposium to educate the community about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation. People who have a BRCA mutation are at relatively high risk for developing ovarian, prostate and male and female breast cancer.

Come learn about genetic counseling, screening for BRCA mutations, misconceptions about hereditary cancer, how BRCA-positive individuals can manage their risk of developing cancer, emotional support resources available for you and your family and the new BRCA Founder Outreach (BFOR) Study being conducted by Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Several people who are BRCA-positive and cancer survivors will share their stories.

Following presentations by each of these panelists, there will be a Q&A session:

Lauren Corduck
Founder & Executive Director
Oneinforty
BRCA-positive ovarian cancer survivor

Camila Gabriel, MS
Senior Research Project Manager, BFOR Study
Center for Cancer Genetics and Prevention
Dana-Farber Cancer Institute

Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Massachusetts General Hospital

Debbi Shamon, LICSW
In private practice in Boston

This symposium is open to the general public. Kosher refreshments will be served.

Feel free to contact Lauren Corduck at laurenc@oneinforty.org or 617-823-3630 with any questions you may have about the symposium.

+ More... - Less...
Fact Sheet
When
Wednesday, May 23, 2018, 7:00 pm - 9:00 pm
* Registration closes on May 24th
Where
Temple Beth Elohim
10 Bethel Rd
Wellesley, MA 02481
Organized By
Price
Free

More In...

More At...